Mindmed announces participation at upcoming investor conferences

New york, sept. 21, 2021 /prnewswire/ -- mind medicine (mindmed) inc. (nasdaq: mnmd), (neo: mmed), (de: mmq) (the "company"), a leading biotech company developing psychedelic-inspired therapies, today announces that robert barrow, chief executive officer of mindmed, will participate in the following investor conferences: advances in mental health virtual conference , presented by maxim group llc and hosted by m-vest  live sessions date:  wednesday, sept.
MNMD Ratings Summary
MNMD Quant Ranking